Koninklijke Philips (PHG) Cash from Operations Growth (3y) (2012 - 2026)
Koninklijke Philips (PHG) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn | 27.41% |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn | 22.38% |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn | 30.85% |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 168.71% |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn | 12.26% |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn | 65.19% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 43.79% |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn | 9.30% |
| 10 | Zimmer Biomet Holdings | 19.39 Bn | 18.98 Bn | 1.54 Bn | 8.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.79% |
| Mar 31, 2026 | 0.50% |
| Dec 31, 2025 | 123.56% |
| Sep 30, 2025 | 60.13% |
| Jun 30, 2025 | 40.44% |
| Mar 31, 2025 | -56.76% |
| Dec 31, 2024 | 28.36% |
| Sep 30, 2024 | -11.28% |
| Jun 30, 2024 | -30.47% |
| Mar 31, 2024 | -35.35% |
| Dec 31, 2023 | -3.34% |
| Sep 30, 2023 | -7.46% |
| Jun 30, 2023 | -33.11% |
| Mar 31, 2023 | 2.76% |
| Dec 31, 2022 | -27.62% |
| Sep 30, 2022 | -34.96% |
| Jun 30, 2022 | -48.85% |
| Mar 31, 2022 | -162.12% |
| Dec 31, 2021 | -17.67% |
| Sep 30, 2021 | -0.69% |